dermatan sulfate has been researched along with methotrexate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Antunes, E; Baú, EC; De Nucci, G; Dietrich, CP; Marcondes, S; Nader, HB | 1 |
| Alvarez-Lorenzo, C; Blanco-Fernández, B; Concheiro, A; Costoya, A; Curcio, M; Puoci, F | 1 |
1 review(s) available for dermatan sulfate and methotrexate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for dermatan sulfate and methotrexate
| Article | Year |
|---|---|
Inhibition of heparin synthesis by methotrexate in rats in vivo.
Topics: Animals; Dermatan Sulfate; Dermatologic Agents; Edema; Heparin; Histamine; Male; Methotrexate; p-Methoxy-N-methylphenethylamine; Rats; Rats, Wistar; Skin; Supine Position | 2002 |
Glucose cryoprotectant affects glutathione-responsive antitumor drug release from polysaccharide nanoparticles.
Topics: Animals; Antimetabolites, Antineoplastic; BALB 3T3 Cells; Cell Survival; Chemistry, Pharmaceutical; Chitosan; CHO Cells; Chondroitin Sulfates; Cricetulus; Cross-Linking Reagents; Cryoprotective Agents; Dermatan Sulfate; Dose-Response Relationship, Drug; Drug Carriers; Female; Freeze Drying; Glucose; Glutathione; HeLa Cells; Humans; Kinetics; Methotrexate; Mice; Microscopy, Confocal; Nanomedicine; Nanoparticles; Polymethacrylic Acids; Polysaccharides; Solubility; Technology, Pharmaceutical; Uterine Cervical Neoplasms | 2015 |